Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  PuriCore plc    PURI   GB00B3XBCR18

PURICORE PLC (PURI)

2
Delayed Quote. Delayed London Stock Exchange - 12/18 03:01:46 am
30.8625 GBp   -1.63%
11/25 PURICORE : To Invest Disposal Cash Rather Than Return To Shareholder..
11/25 PURICORE : Strategic and Operational Review Update
11/24 PURICORE : Result of General Meeting
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

PuriCore plc : PuriCore Raises $3.5 Million

01/03/2012 | 03:11pm US/Eastern
PuriCore plc ("PuriCore" or the "Company" or the "Group") PuriCore Raises $3.5 Million MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 3 January 2012 - PuriCore (LSE: PURI), the water- based clean technology company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, announces that it closed on a new $3.5 million debt facility with Republic Bank on 29 December 2011. The debt will be utilized to finance the working capital requirements associated with Sterilox Fresh and FloraFresh System installations in H1 2012. The facility is structured as a promissory note with an imputed interest rate of 4%. Enquiries:

FTI Consulting Susan Quigley Ben Brewerton

+44 (0) 20 7831 3113

About PuriCore

PuriCoreplc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. The Company's products are used in a broad range of markets that depend upon controlling contamination, including food retail and foodservice, medical device disinfection, and wound care. PuriCore's solutions are proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of C.difficile, E.coli, HIV, Human and Animal Influenza (including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and Salmonella. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK.
To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.

1

React to this article
Latest news on PURICORE PLC
11/26 PURICORE : Preliminary Decisions Arising From The On-Going Strategic And Operati..
11/25 PURICORE : To Invest Disposal Cash Rather Than Return To Shareholders
11/25 PURICORE : Strategic and Operational Review Update
11/24 PURICORE : Result of General Meeting
11/09 PURICORE : Proposed listing changes and notice of GM
11/09 PURICORE : granted two U.S. patents
11/07 PURICORE : Assigned Patent
11/07 PURICORE : Proposes Move To AIM From Main Market
11/05 PURICORE : Granted Two U.S. Patents
11/05 PURICORE : Wins Two New Patents In US For Hypochlorous Acid Products
Advertisement
Chart
Duration : Period :
PuriCore plc Technical Analysis Chart | PURI | GB00B3XBCR18 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF